Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Berger

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Psychotherapie, Psychosomatik, Medizinische Psychologie|March 25, 2011
[Screening of disordered eating in 12-Year-old girls and boys: psychometric analysis of the German versions of SCOFF and EAT-26]Uwe Berger, Katharina Wick, Heike Hölling, et al.
Clinical and Translational Allergy|September 22, 2017
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA<sup>2</sup>LEN studyGeorg Boelke, Uwe Berger, Karl-Christian Bergmann, et al.
The Journal of Allergy and Clinical Immunology|September 6, 2017
Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergyTamar Kinaciyan, Birgit Nagl, Sandra Faustmann, et al.
The Journal of Allergy and Clinical Immunology|June 7, 2015
Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patientsVerena Niederberger, Katharina Marth, Julia Eckl-Dorna, et al.
The Science of the Total Environment|January 24, 2016
First comparison of symptom data with allergen content (Bet v 1 and Phl p 5 measurements) and pollen data from four European regions during 2009-2011Katharina Bastl, Maximilian Kmenta, Anna-Mari Pessi, et al.
The World Allergy Organization Journal|September 22, 2017
The grass pollen season 2015: a proof of concept multi-approach study in three different European citiesMaximilian Kmenta, Katharina Bastl, Uwe Berger, et al.
The Journal of Allergy and Clinical Immunology|November 25, 2018
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanismsRaffaela Campana, Katharina Marth, Petra Zieglmayer, et al.
The World Allergy Organization Journal|April 3, 2019
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen seasonRalph Mösges, Nils Y Breitrück, Silke Allekotte, et al.
Allergy|February 3, 2022
Development of the EAACI% season definition a backup for a global applicationMaximilian Bastl, Markus Berger, Katharina Bastl, et al.
International Archives of Allergy and Immunology|May 10, 2018
Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 CountriesJean Bousquet, Ioana Agache, Uwe Berger, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Psychotherapie, Psychosomatik, Medizinische Psychologie|March 25, 2011
[Screening of disordered eating in 12-Year-old girls and boys: psychometric analysis of the German versions of SCOFF and EAT-26]Uwe Berger, Katharina Wick, Heike Hölling, et al.
Clinical and Translational Allergy|September 22, 2017
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA<sup>2</sup>LEN studyGeorg Boelke, Uwe Berger, Karl-Christian Bergmann, et al.
The Journal of Allergy and Clinical Immunology|September 6, 2017
Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergyTamar Kinaciyan, Birgit Nagl, Sandra Faustmann, et al.
The Journal of Allergy and Clinical Immunology|June 7, 2015
Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patientsVerena Niederberger, Katharina Marth, Julia Eckl-Dorna, et al.
The Science of the Total Environment|January 24, 2016
First comparison of symptom data with allergen content (Bet v 1 and Phl p 5 measurements) and pollen data from four European regions during 2009-2011Katharina Bastl, Maximilian Kmenta, Anna-Mari Pessi, et al.
The World Allergy Organization Journal|September 22, 2017
The grass pollen season 2015: a proof of concept multi-approach study in three different European citiesMaximilian Kmenta, Katharina Bastl, Uwe Berger, et al.
The Journal of Allergy and Clinical Immunology|November 25, 2018
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanismsRaffaela Campana, Katharina Marth, Petra Zieglmayer, et al.
The World Allergy Organization Journal|April 3, 2019
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen seasonRalph Mösges, Nils Y Breitrück, Silke Allekotte, et al.
Allergy|February 3, 2022
Development of the EAACI% season definition a backup for a global applicationMaximilian Bastl, Markus Berger, Katharina Bastl, et al.
International Archives of Allergy and Immunology|May 10, 2018
Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 CountriesJean Bousquet, Ioana Agache, Uwe Berger, et al.
Pageof 8